-
Tata India Pharma & Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 11/03/26 )
NAV
₹29.86
Last change
₹0.03 +0.0%
Fund Size (AUM)
1300.81 Cr
Performance
15.34% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Growth
as of 11/03/26
AUM
1300.81 Cr
Expense Ratio
2.14 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K016A9
Fund Manager
Rajat Srivastava
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Growth | 8.99% | 24.16% | 15.34% |
| Nifty Pharma TR INR | 14.93% | 26.68% | 16.06% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
9.66% |
Max Healthcare Institute Ltd Ordinary Shares |
6.78% |
Divi's Laboratories Ltd |
5.94% |
Abbott India Ltd |
5.6% |
HealthCare Global Enterprises Ltd |
5.04% |
Apollo Hospitals Enterprise Ltd |
5.0% |
Cipla Ltd |
4.55% |
Rainbow Childrens Medicare Ltd |
3.83% |
Mankind Pharma Ltd |
3.4% |
Bayer CropScience Ltd |
3.33% |
Sector Allocation
Healthcare |
96.58% |
Basic Materials |
3.42% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Fund
Equity healthcare-
Returns
-
17.02% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R Fund
Equity healthcare-
Returns
-
16.36% (5Y)
-
-
SBI Healthcare Opportunities Fund
Equity healthcare-
Returns
-
17.03% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R Fund
Equity healthcare-
Returns
-
17.03% (5Y)
-
-
UTI Healthcare IDCW-P Fund
Equity healthcare-
Returns
-
15.31% (5Y)
-
-
UTI Healthcare IDCW-R Fund
Equity healthcare-
Returns
-
15.31% (5Y)
-
